Active Not RecruitingNCT07316088
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms
Device studyAges 18+United States
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- TallahasseeSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 9, 2025
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Oui Therapeutics, Inc.
- Sponsor type
- Biotech company
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07316088
- Official title
Show the full official title
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms in a Randomized Controlled Trial (RCT)
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tallahassee
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Oui Therapeutics, Inc.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
